ODDB.org: Open Drug Database

GlaxoSmithKline AG - Engerix-B 10, Injektionssuspension

Swissmedic Registration	00551	Sequence	03
Product name	Engerix-B 10	Description	Injektionssuspension
ATC-Classification	J07BC01	ATC-Description	Hepatitis B, Purified Antigen
Introduction of Sequence	01.05.2002

Composition

hepatitidis B viri antigenum ADNr 10 µg, aluminium 0.25 mg ut aluminii hydroxidum, natrii chloridum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.75 mg.

Packungsbestandteile

Galenic Form

Injection suspension

Excipiens

Active Agent	Dose
Hepatitidis b viri Antigenum Adnr	10µg / 0.5ml

BAG: Active Agent	Dose
Vaccinum Hepatitidis b (Adnr) Hbsag	10 mcg

Inactive agents	Dose
Alumine	0.25mg / 0.5ml
Disodium Phosphate Dihydrate
Sodium Chloride
Sodium Dihydrogenophosphate Dihydrate

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
004		20.83	39.05	B	SL	No

2025	©ywesee GmbH